Advisory Committee Again Urges FDA to Vote No on Aducanumab
After news on “new data” they won’t see, three committee members argue against approval.
16 RESULTS
Sort By:
Go to another page:
After news on “new data” they won’t see, three committee members argue against approval.
Go to another page: